Your browser doesn't support javascript.
loading
Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel.
Kovács, Norbert; Bergmann, Lars; Anca-Herschkovitsch, Marieta; Cubo, Esther; Davis, Thomas L; Iansek, Robert; Siddiqui, Mustafa S; Simu, Mihaela; Standaert, David G; Chaudhuri, K Ray; Bourgeois, Paul; Gao, Tianming; Kukreja, Pavnit; Pontieri, Francesco E; Aldred, Jason.
Afiliación
  • Kovács N; University of Pécs, Medical School, Pécs, Hungary.
  • Bergmann L; AbbVie Inc., North Chicago, IL, USA.
  • Anca-Herschkovitsch M; Edith Wolfson Medical Center, Holon, Israel.
  • Cubo E; Neurology Department, Hospital Universitario Burgos, Burgos, Spain.
  • Davis TL; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Iansek R; Kingston Centre, Monash Health, Melbourne, Australia.
  • Siddiqui MS; Wake Forest School of Medicine, Winston Salem, NC, USA.
  • Simu M; Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
  • Standaert DG; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Chaudhuri KR; Parkinson's Foundation International Centre of Excellence, King's College Hospital, London, UK.
  • Bourgeois P; King's College Institute of Psychiatry, Psychology & Neuroscience, London, UK.
  • Gao T; Department of Neurology AZ Groeninge, Kortrijk, Belgium.
  • Kukreja P; AbbVie Inc., North Chicago, IL, USA.
  • Pontieri FE; AbbVie Inc., North Chicago, IL, USA.
  • Aldred J; Sapienza University of Rome, Rome, Italy.
J Parkinsons Dis ; 12(3): 917-926, 2022.
Article en En | MEDLINE | ID: mdl-34974438
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Carbidopa / Levodopa Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Parkinsons Dis Año: 2022 Tipo del documento: Article País de afiliación: Hungria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Carbidopa / Levodopa Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Parkinsons Dis Año: 2022 Tipo del documento: Article País de afiliación: Hungria